PT Pyridam Farma Tbk engages in the development, production, and trading of pharmaceuticals primarily in Indonesia. The company operates in two segments, Pharmaceutical Products, Esthetic, and Toll Manufacturing Services; and Medical Equipments. It supplies medical instruments and equipment, including clinical waste, collection swab, collection tube, innerbox DCA, KF94 mask, parafilm, PCR – extraction kit and extractor machine, speciment bag, sterile container, PCR machine- Gentier 48, and tube stopper. The company also provides skin care products comprising Arosa gel, A-Stark Gel, Hymen gel, Pyderen Emulsion, Tonic Bust Emulsion, Calmosan Cream, and Di-Herb gel; medical support products; over the counter, ethical, and sigma products in the areas of musculo-skeletal, cardiovascular and hematopoietic system, genito urinary system, and respiratory system, as well as mineral and health supplements, vitamins, and other consumer health products in the form of syrups, tablets, and capsules; and sanitizers and antiseptics. PT Pyridam Farma Tbk was founded in 1976 and is headquartered in Jakarta Selatan, Indonesia. PT Pyridam Farma Tbk is a subsidiary of Rejuve Global Investment Pte. Ltd.
Metrics to compare | PYFA | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipPYFAPeersSector | |
---|---|---|---|---|
P/E Ratio | −12.6x | 17.5x | −0.7x | |
PEG Ratio | −0.15 | −0.17 | 0.00 | |
Price/Book | 2.6x | 1.5x | 2.6x | |
Price / LTM Sales | 2.3x | 1.5x | 3.2x | |
Upside (Analyst Target) | - | 14.2% | 44.1% | |
Fair Value Upside | Unlock | 10.5% | 8.2% | Unlock |